NC
GILD icon

Napatree Capital’s Gilead Sciences GILD Stock Holding History

Napatree Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$475K Sell
4,239
-1,981
-32% -$204K 0.27% 101
2024
Q4 		$575K Buy
6,220
+971
+18% +$87.4K 0.34% 80
2024
Q3 		$440K Sell
5,249
-548
-9% -$41.8K 0.31% 92
2024
Q2 		$398K Sell
5,797
-2,907
-33% -$194K 0.32% 90
2024
Q1 		$568K Buy
8,704
+118
+1% +$9.07K 0.55% 70
2023
Q4 		$696K Buy
+8,586
New +$668K 0.7% 59

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Napatree Capital's GILD Position: Q1 2025 in Review

Napatree Capital reduced its Gilead Sciences (GILD) stake by 32% in Q1 2025, selling an estimated $204K and leaving 4,239 shares worth $475K. The position accounts for 0.27% of the portfolio, ranked #101.

Napatree Capital first reported a position in GILD in Q4 2023 and has held it in 6 quarters since. The position peaked at $696K in Q4 2023. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Napatree Capital held 4,239 shares of Gilead Sciences worth $475K as of Q1 2025.
  • Napatree Capital sold 1,981 Gilead Sciences shares in Q1 2025, an estimated $204K.
  • Gilead Sciences made up 0.27% of Napatree Capital's portfolio in Q1 2025, its #101 holding.
  • Napatree Capital first reported a position in Gilead Sciences in Q4 2023 and has held it in 6 quarters since.
  • Napatree Capital's Gilead Sciences position peaked at $696K in Q4 2023.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Napatree Capital's 13F filing for Q1 2025, filed 2 May 2025.